Skip to main content

Table 3 Abnormal pulmonary ultrasonographic findings and clinical course of the SARS-CoV-2 infection

From: Detection of residual pulmonary alterations with lung ultrasound and effects on postoperative pulmonary complications for patients with asymptomatic SARS-CoV-2 infection undergoing surgeries

Pleural thickening

B-lines (≥ 3)

 

No, 74 (71.84)

Yes, 29 (28.15)

p-value

No, 78 (75.72)

Yes, 25 (24.27)

p-value

Covid19-Surgery

109 ± 84.31

106.93 ± 77.37

0.33

115.23 ± 84.90

88 ± 70.03

0.15

Hospitalization days

2.65 ± 6.85

12.90 ±26.35

0.000

3.28 ± 7.19

12.56 ±28.46

0.11

ICU days

0.34 ±1.46

6.24 ±17.28

0.01

0.72 ±3.68

6.00 ±17.88

0.04

NIMV days

0.23 ± 1.58

1.34 ± 3.02

0.002

0.36 ± 1.84

1.12 ± 2.82

0.42

IMV days

0.09 ± 0.81

4.34 ± 13.65

0.03

0.41 ± 2.93

4.04 ± 14.04

0.06

Cough

22 (29.7)

10 (34.5)

0.64

24 (30.8)

8 (32.0)

0.91

Dyspnea

14 (18.9)

14 (48.3)

0.003

19 (24.4)

9 (36.0)

0.25

Fever

24 (32.4)

16 (55.2)

0.03

30 (38.5)

10 (40.0)

0.89

Digestive disorders

13 (17.6)

7 (24.1)

0.45

15 (19.2)

5 (20.0)

0.93

Pneumonia

19 (25.7)

16 (55.2)

0.004

24 (30.8)

11 (44.0)

0.22

Venous thrombosis

0 (0.0)

1 (3.4)

0.11

0 (0.0)

1 (4.0)

0.07

PTE

1 (1.4)

0 (13.8)

0.53

1 (1.3)

0 (0.0)

0.53

ARDS

0 (0.0)

4 (34.5)

0.001

2 (2.6)

2 (8.0)

0.01

Vasoactive drugs

1 (1.4)

3 (10.3)

0.02

1 (1.3)

3 (12.0)

0.01

  1. COVID-19-Surgery: Days elapsed from diagnosis of SARS-CoV-2 infection to the day of surgery. ICU Intensive Care Unit. NIMV Non-invasive mechanical ventilation, IMV Invasive mechanical ventilation, PTE Pulmonary thromboembolism, ARDS Acute respiratory distress syndrome. Data are expressed as mean ± SD, and number (percentage)
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us